|
Volumn 27, Issue 3, 1998, Pages 679-684
|
Open-label trial of oral nalmefene therapy for the pruritus of cholestasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NALMEFENE;
OPIATE ANTAGONIST;
ABDOMINAL PAIN;
ADOLESCENT;
ADULT;
ANXIETY NEUROSIS;
ARTICLE;
CHOLESTASIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DEPERSONALIZATION;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INSOMNIA;
LONG TERM CARE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PRURITUS;
RISK BENEFIT ANALYSIS;
SCHOOL CHILD;
WITHDRAWAL SYNDROME;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
CHILD;
CHOLESTASIS;
HUMANS;
MIDDLE AGED;
NALTREXONE;
NARCOTIC ANTAGONISTS;
PRURITUS;
|
EID: 0031952421
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510270307 Document Type: Article |
Times cited : (165)
|
References (9)
|